Gnomica Biotherapy Revenue
Biotechnology Research • • 1-10 Employees
$
Gnomica Biotherapy revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Gnomica Biotherapy
Yuval Raviv
Co-Founder
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Gnomica Biotherapy Email Formats
Gnomica Biotherapy uses 1 email format. The most common is {first name} (e.g., john@gnomica.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@gnomica.com | 100% |
About Gnomica Biotherapy
We at Gnomica are developing small-molecule drug inhibitors targeting bacterial pathways to treat cancer. Follow us on Twitter: @GnomicaBio
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Gnomica Biotherapy has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Gnomica Biotherapy has never raised funding before.
United States
Italy
Germany
AustraliaFrequently asked questions
Gnomica Biotherapy is located in XX.
Gnomica Biotherapy generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
Gnomica Biotherapy has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Gnomica Biotherapy was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
Gnomica Biotherapy has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
